Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
| Autor: | N. D. Jayaweerabandara, A. G. H. Sugathapala, S. Pirasath, A. R. M. Misthaq |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Hepatitis
medicine.medical_specialty business.industry Urinary system Infectious and parasitic diseases RC109-216 medicine.disease Asymptomatic Gastroenterology Ciprofloxacin Fluoroquinolone Antibiotic Cholestasis Internal medicine ciprofloxacin cholestasis hepatitis toxicity medicine medicine.symptom Adverse effect business Fulminant hepatitis medicine.drug |
| Zdroj: | Sri Lankan Journal of Infectious Diseases, Vol 9, Iss 2, Pp 156-159 (2019) |
| ISSN: | 2448-9654 2012-8169 |
| DOI: | 10.4038/sljid.v9i2.8256 |
| Popis: | Ciprofloxacin has generally been well-tolerated and is the commonly prescribed fluoroquinolone antibiotic for treatment of urinary tract and gastrointestinal infection. The adverse effects on the liver usually range from asymptomatic elevation of liver enzymes to fulminant hepatitis. However, acute fulminant hepatitis and cholestatic hepatitis are reported rarely in literature. Here, we report a case of ciprofloxacin induced cholestatic hepatitis in a 52 year old woman following intravenous ciprofloxacin for acute gastroenteritis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|